TAFINLAR 75 MG 120 CAP

Tafinlar (dabrafenib) is a medication primarily used in the treatment of melanoma, particularly melanoma that has a specific genetic mutation known as BRAF V600E or BRAF V600K mutation. The formulation you’ve mentioned, Tafinlar 75 mg capsules, contains dabrafenib as the active ingredient. Each capsule typically contains 75 mg of dabrafenib along with other inactive ingredients. Dabrafenib is classified as a BRAF inhibitor. It works by inhibiting the activity of the BRAF protein, which is involved in cell signaling pathways that regulate cell growth and division. By targeting cells with the BRAF mutation, dabrafenib helps to slow down or stop the growth of cancer cells, thereby aiding in the treatment of melanoma. As with any medication, it’s crucial to take Tafinlar exactly as prescribed by your doctor. The dosage and duration of treatment may vary depending on factors such as the type and stage of cancer, your overall health, and other medications you may be taking. Always follow your doctor’s instructions carefully and report any side effects or concerns promptly.